Gut mucosal immune cells and immune signaling pathways

The gut mucosal immune system is a sophisticated network of immune cells and signaling pathways located within the gastrointestinal tract, primarily organized into the gut-associated lymphoid tissue (GALT), lamina propria, and epithelial layer (Mowat & Agace, 2014, Nature Reviews Immunology). It serves as the body's largest immune compartment, responsible for maintaining a delicate balance between tolerance to commensal microbiota and food antigens while mounting robust responses against pathogens (NIH, 2023). Dysregulation of these immune cells and their signaling pathways, such as the JAK/STAT or IL-23/Th17 axes, is a primary driver of chronic inflammatory conditions like Crohn's disease and ulcerative colitis (StatPearls, 2023). Modern pharmacotherapy targets specific nodes within this network, such as TNF-alpha, integrin alpha-4 beta-7, and various Janus kinases, to induce clinical remission and mucosal healing (PubChem, 2024). Because this entry encompasses a vast array of distinct cell types and molecular interactions rather than a single protein, it is classified as a biological system or therapeutic area rather than a discrete molecular target.

Other names

Gut-associated lymphoid tissueGALTMucosal immune systemIntestinal immune systemIntestinal mucosal immunity

Therapeutic agents modulate this system by inhibiting pro-inflammatory cytokines (e.g., TNF-alpha, IL-12, IL-23), blocking leukocyte trafficking to the gut (e.g., alpha-4 beta-7 integrin antagonism), or inhibiting intracellular signaling cascades (e.g., JAK/STAT pathway) to restore intestinal homeostasis (PubChem, 2024; StatPearls, 2023).